[Congenital coronary fistulas: the most frequent congenital coronary anomaly]

M Bauer1, U Bauer, V Alexi-Meskishvili

  • 1Klinik für Herz-, Thorax- und Gefässchirurgie Deutsches Herzzentrum Berlin Augustenburger Platz 1 13353 Berlin, Germany. mbauer@dhzb.de

Zeitschrift Fur Kardiologie
|September 22, 2001
PubMed

Insights

Surgical repair of congenital arteriovenous coronary fistulae is effective, with 93% of patients achieving good outcomes. Surgery is recommended for symptomatic patients, those with significant shunts, or complex cases, especially when interventional therapy fails.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Congenital Heart Disease

Background:

  • Congenital arteriovenous coronary fistulae are rare direct communications between coronary arteries and cardiac chambers or great vessels.
  • Diagnosis is often incidental during cardiac catheterization for other conditions.
  • Treatment strategies, including surgical versus interventional approaches, remain debated.

Purpose of the Study:

  • To summarize surgical treatment experience for congenital arteriovenous coronary fistulae.
  • To analyze outcomes in relation to patient symptoms, fistula characteristics, and co-existing cardiac conditions.
  • To provide recommendations for surgical intervention in specific patient groups.

Main Methods:

  • Retrospective analysis of 14 patients undergoing surgical fistula closure at Deutsches Herzzentrum Berlin (1988-1997).
  • Evaluation of preoperative symptomatic status (NYHA class), angiographic data, and surgical techniques.
  • Assessment of late clinical outcomes and comparison with interventional attempts.

Main Results:

  • The study included 14 patients (7 male, 7 female, age 3-67 years).
  • Common drainage sites included the pulmonary artery (8 cases) and superior vena cava/right atrium (2 cases).
  • Twelve patients had concomitant cardiac diseases requiring surgery.
  • All surgical procedures were uneventful, with 93% of patients in good clinical condition (NYHA I-II) at mean 6.6-year follow-up.

Conclusions:

  • Surgical closure is a safe and effective treatment for congenital arteriovenous coronary fistulae.
  • Intervention is recommended for symptomatic patients, those with hemodynamically significant shunts, and complex or larger fistulae.
  • Surgery is particularly indicated for patients with associated cardiac conditions or when interventional therapy has failed.

Related Concept Videos

Chambers of the Heart01:16

Chambers of the Heart

The human heart is a complex organ made up of four chambers: the right and left atria and the right and left ventricles. These internal chambers are separated by partitions known as the interatrial and interventricular septa. The exterior of the heart features a groove known as the coronary sulcus that demarcates the atria from the ventricles, while the anterior and posterior interventricular sulci distinguish between the two ventricles.
Deoxygenated blood from the body is received in the right...
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...